1-(4-氯-2-羟基苯基)-1-丙酮 | 1127-97-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-(4-氯-2-羟基苯基)-1-丙酮
• 英文名称: 1-(4-chloro-2-hydroxy-phenyl)-propan-1-one
• 英文别名: 1-(4-chloro-2-hydroxyphenyl)propan-1-one；4-chloro-2-hydroxypropiophenone；2-n-Propanoyl-5-chlorophenol；1-(4-Chlor-2-hydroxy-phenyl)-propan-1-on；2-hydroxy-4-chloropropiophenone
• CAS: 1127-97-5
• 化学式: C₉H₉ClO₂
• mdl: MFCD00218578
• 分子量: 184.622
• InChiKey: PQDGSZQBDYECBM-UHFFFAOYSA-N

物化性质

• 熔点：
  49 °C

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2914700090
• 危险品标志：
  Harmful

反应信息

• 作为反应物：
  描述：

  1-(4-氯-2-羟基苯基)-1-丙酮 在 溶剂黄146 作用下， 生成 5-Chlor-2-<2-dimethylaminomethyl-propionyl>-phenoxyessigsaeure
  参考文献：
  名称：

  BE612755

  摘要：

  公开号：
• 作为产物：
  描述：

  3-chlorophenyl propionate 在 aluminum (III) chloride 作用下， 以 氯仿 为溶剂， 反应 142.0h， 以26%的产率得到1-(4-氯-2-羟基苯基)-1-丙酮
  参考文献：
  名称：

  不对称和单体罗布定类似物的革兰氏阳性和革兰氏阴性抗生素活性

  摘要：

  罗非替丁的去对称化（1：N '，2-二（（E）-4-氯苄叉）肼-1-羧酰亚胺肼）和亚胺烷基取代基的引入具有良好的抗生素活性。值得注意的是，两种类似物对耐万古霉素的肠球菌（VRE）的效力有所提高，其中一种的MIC为0.5μgmL -1。发现有五个类似物比铅1具有更强的效价。吲哚部分的引入导致针对甲氧西林抗性金黄色葡萄球菌（MRSA）的活性最强的robenidine类似物，MIC为1.0μgmL -1。亚胺C = NH等位基因（C = O / C = S）不活跃。单体类似物为16–64μgmL-1对MRSA和VRE有效。缺少末端酰肼NH部分的类似物在64μgmL -1下显示适度的革兰氏阴性活性。研究表明，在16–64μgmL -1下， 4-叔丁基类似物对革兰氏阳性和阴性菌株均具有活性。通常，除伴随引入亚胺C-烷基外，对芳香族基团的其他修饰耐受性差。这些类似物对MRSA和VRE的活性范围为8μgmL

  DOI：

  10.1002/cmdc.201800463

文献信息

• Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
  申请人：Lynch K. John

  公开号：US20050209274A1

  公开（公告）日：2005-09-22

  The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

  本发明涉及式(I)的化合物，通过对抗黑素浓集激素（MCH）的作用，通过对抗黑素浓集激素受体，有助于预防或治疗进食障碍、体重增加、肥胖、生殖和性行为异常、甲状腺激素分泌、利尿和水/电解质稳态、感觉处理、记忆、睡眠、觉醒、焦虑、抑郁、癫痫、神经退行性疾病和精神障碍。
• Broadening the catalyst and reaction scope of regio- and chemoselective C–H oxygenation: a convenient and scalable approach to 2-acylphenols by intriguing Rh(ii) and Ru(ii) catalysis
  作者：Gang Shan、Xuesong Han、Yun Lin、Shanyou Yu、Yu Rao

  DOI：10.1039/c3ob27457h

  日期：——

  catalyzed C–H oxygenation of aryl ketones and other arenes has been developed for the facile synthesis of diverse functionalized phenols. The reaction demonstrates excellent reactivity, regio- and chemoselectivity, good functional group compatibility and high yields. The practicality of this method has been proved by gram-scale synthesis of a few different 2-acylphenols. Its utility has been well exemplified

  已开发出一种独特的Rh（II）和Ru（II）催化的芳基酮和其他芳烃的CH氧化反应，可以轻松合成各种功能化的酚。该反应显示出优异的反应性，区域和化学选择性，良好的官能团相容性和高产率。该方法的实用性已通过克级合成几种不同的2-酰基酚得到了证明。它的效用已在杂环合成和药物的直接修饰中的进一步应用中得到很好的例证非诺贝特。
• Synthesis of Tetrasubstituted Enamines through Borane-Catalyzed Hydrogenations
  作者：Zijia Zhang、Xiangqing Feng、Haifeng Du

  DOI：10.1021/acs.orglett.3c03578

  日期：2023.12.29

  This paper describes a B(C6F5)3-catalyzed hydrogenation of β-substituted α,β-unsaturated imines by using as low as 0.2 mol % catalyst. A variety of tetrasubstituted enamines were afforded in 95–99% yields. It provides an efficient and facile way without the need for column chromatography purification.

  本文描述了使用低至0.2 mol% 的催化剂进行B(C 6 F 5 ) 3催化的β-取代的α,β-不饱和亚胺的氢化反应。多种四取代烯胺的产率达到 95-99%。它提供了一种有效且简便的方法，无需柱色谱纯化。
• Optimization of Chromone-2-carboxamide Melanin Concentrating Hormone Receptor 1 Antagonists:  Assessment of Potency, Efficacy, and Cardiovascular Safety
  作者：John K. Lynch、Jennifer C. Freeman、Andrew S. Judd、Rajesh Iyengar、Mathew Mulhern、Gang Zhao、James J. Napier、Dariusz Wodka、Sevan Brodjian、Brian D. Dayton、Doug Falls、Christopher Ogiela、Regina M. Reilly、Thomas J. Campbell、James S. Polakowski、Lisa Hernandez、Kennan C. Marsh、Robin Shapiro、Victoria Knourek-Segel、Brian Droz、Eugene Bush、Michael Brune、Lee C. Preusser、Ryan M. Fryer、Glenn A. Reinhart、Kathryn Houseman、Gilbert Diaz、Ann Mikhail、James T. Limberis、Hing L. Sham、Christine A. Collins、Philip R. Kym

  DOI：10.1021/jm060683e

  日期：2006.11.1

  Evaluation of multiple structurally distinct series of melanin concentrating hormone receptor 1 antagonists in an anesthetized rat cardiovascualar assay led to the identification of a chromone-2-carboxamide series as having excellent safety against the chosen cardiovascular endpoints at high drug concentrations in the plasma and brain. Optimization of this series led to considerable improvements in affinity, functional potency, and pharmacokinetic profile. This led to the identification of a 7-fluorochromone-2-carboxamide (22) that was orally efficacious in a diet-induced obese mouse model, retained a favorable cardiovascular profile in rat, and demonstrated dramatic improvement in effects on mean arterial pressure in our dog cardiovascular model compared to other series reported by our group. However, this analogue also led to prolongation of the QT interval in the dog that was linked to affinity for hERG channel and unexpectedly potent functional blockade of this ion channel.
• BE639727
  申请人：——

  公开号：——

  公开（公告）日：——